These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 15492240)

  • 1. Cleavage of beta-catenin by calpain in prostate and mammary tumor cells.
    Rios-Doria J; Kuefer R; Ethier SP; Day ML
    Cancer Res; 2004 Oct; 64(20):7237-40. PubMed ID: 15492240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beta-catenin-related anomalies in apoptosis-resistant and hormone-refractory prostate cancer cells.
    de la Taille A; Rubin MA; Chen MW; Vacherot F; de Medina SG; Burchardt M; Buttyan R; Chopin D
    Clin Cancer Res; 2003 May; 9(5):1801-7. PubMed ID: 12738737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional localization and competition between the androgen receptor and T-cell factor for nuclear beta-catenin: a means for inhibition of the Tcf signaling axis.
    Mulholland DJ; Read JT; Rennie PS; Cox ME; Nelson CC
    Oncogene; 2003 Aug; 22(36):5602-13. PubMed ID: 12944908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transactivation of vimentin by beta-catenin in human breast cancer cells.
    Gilles C; Polette M; Mestdagt M; Nawrocki-Raby B; Ruggeri P; Birembaut P; Foidart JM
    Cancer Res; 2003 May; 63(10):2658-64. PubMed ID: 12750294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Galectin-3, a novel binding partner of beta-catenin.
    Shimura T; Takenaka Y; Tsutsumi S; Hogan V; Kikuchi A; Raz A
    Cancer Res; 2004 Sep; 64(18):6363-7. PubMed ID: 15374939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rare activation of the TCF/beta-catenin pathway in ovarian cancer.
    Furlong MT; Morin PJ
    Gynecol Oncol; 2000 Apr; 77(1):97-104. PubMed ID: 10739697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Redundant expression of canonical Wnt ligands in human breast cancer cell lines.
    Benhaj K; Akcali KC; Ozturk M
    Oncol Rep; 2006 Mar; 15(3):701-7. PubMed ID: 16465433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tcf binding sequence and position determines beta-catenin and Lef-1 responsiveness of MMP-7 promoters.
    Gustavson MD; Crawford HC; Fingleton B; Matrisian LM
    Mol Carcinog; 2004 Nov; 41(3):125-39. PubMed ID: 15457508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. P53 mutation as a source of aberrant beta-catenin accumulation in cancer cells.
    Cagatay T; Ozturk M
    Oncogene; 2002 Nov; 21(52):7971-80. PubMed ID: 12439747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beta-catenin mutations in human prostate cancer.
    Voeller HJ; Truica CI; Gelmann EP
    Cancer Res; 1998 Jun; 58(12):2520-3. PubMed ID: 9635571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. beta-catenin (CTNNB1) gene amplification: a new mechanism of protein overexpression in cancer.
    Suriano G; Vrcelj N; Senz J; Ferreira P; Masoudi H; Cox K; Nabais S; Lopes C; Machado JC; Seruca R; Carneiro F; Huntsman DG
    Genes Chromosomes Cancer; 2005 Mar; 42(3):238-46. PubMed ID: 15609344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of MYCBP as a beta-catenin/LEF-1 target using DNA microarray analysis.
    Jung HC; Kim K
    Life Sci; 2005 Jul; 77(11):1249-62. PubMed ID: 15979100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SOX9 is expressed in normal prostate basal cells and regulates androgen receptor expression in prostate cancer cells.
    Wang H; McKnight NC; Zhang T; Lu ML; Balk SP; Yuan X
    Cancer Res; 2007 Jan; 67(2):528-36. PubMed ID: 17234760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quercetin, a potent inhibitor against beta-catenin/Tcf signaling in SW480 colon cancer cells.
    Park CH; Chang JY; Hahm ER; Park S; Kim HK; Yang CH
    Biochem Biophys Res Commun; 2005 Mar; 328(1):227-34. PubMed ID: 15670774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beta-catenin can act as a nuclear import receptor for its partner transcription factor, lymphocyte enhancer factor-1 (lef-1).
    Asally M; Yoneda Y
    Exp Cell Res; 2005 Aug; 308(2):357-63. PubMed ID: 15936755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beta-catenin directly displaces Groucho/TLE repressors from Tcf/Lef in Wnt-mediated transcription activation.
    Daniels DL; Weis WI
    Nat Struct Mol Biol; 2005 Apr; 12(4):364-71. PubMed ID: 15768032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Truncated E-cadherin potentiates cell death in prostate epithelial cells.
    Rios-Doria J; Day ML
    Prostate; 2005 May; 63(3):259-68. PubMed ID: 15538719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of the FGF18 gene in colorectal carcinogenesis, as a novel downstream target of the beta-catenin/T-cell factor complex.
    Shimokawa T; Furukawa Y; Sakai M; Li M; Miwa N; Lin YM; Nakamura Y
    Cancer Res; 2003 Oct; 63(19):6116-20. PubMed ID: 14559787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. gamma-Catenin expression is reduced or absent in a subset of human lung cancers and re-expression inhibits transformed cell growth.
    Winn RA; Bremnes RM; Bemis L; Franklin WA; Miller YE; Cool C; Heasley LE
    Oncogene; 2002 Oct; 21(49):7497-506. PubMed ID: 12386812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of Wnt/beta-catenin/Tcf signaling in mouse skin carcinogenesis.
    Bhatia N; Spiegelman VS
    Mol Carcinog; 2005 Apr; 42(4):213-21. PubMed ID: 15765534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.